Display options
Cite
Salgado M, Fernández F, Avilés C, et al. Erythromycin Seromadesis in Orthopedic Surgery. J Orthop Case Rep. 2016;6(2):92-94doi: 10.13107/jocr.2250-0685.454.
Salgado, M., Fernández, F., Avilés, C., & Cordova, C. (2016). Erythromycin Seromadesis in Orthopedic Surgery. Journal of orthopaedic case reports, 6(2), 92-94. https://doi.org/10.13107/jocr.2250-0685.454
Salgado, Martin, et al. "Erythromycin Seromadesis in Orthopedic Surgery." Journal of orthopaedic case reports vol. 6,2 (2016): 92-94. doi: https://doi.org/10.13107/jocr.2250-0685.454
Salgado M, Fernández F, Avilés C, Cordova C. Erythromycin Seromadesis in Orthopedic Surgery. J Orthop Case Rep. 2016 Apr-Jun;6(2):92-94. doi: 10.13107/jocr.2250-0685.454. PMID: 27703947; PMCID: PMC5040586.
Copy Download .nbib Format: NLM
Share it on

J Orthop Case Rep. 2016 Apr-Jun;6(2):92-94. doi: 10.13107/jocr.2250-0685.454.

Erythromycin Seromadesis in Orthopedic Surgery.

Journal of orthopaedic case reports

Martin Salgado, Felipe Fernández, Carolina Avilés, Cecilia Cordova

Affiliations

  1. Department of Traumatology and Orthopedics Hospital of the Catholic University of Chile. Santiago, Chile; Section of Reconstructive Joint Surgery Division: Pelvis, Hip and Thigh. Dr. Sotero del Rio Hospital. Santiago, Chile.
  2. Department of Traumatology and Orthopedics Hospital of the Catholic University of Chile. Santiago, Chile.

PMID: 27703947 PMCID: PMC5040586 DOI: 10.13107/jocr.2250-0685.454

Abstract

INTRODUCTION: The presence of postoperative seromadesis is common, corresponding to the presence of serum in the subcutaneous tissue post a surgical event. Erythromycin has been reported as sclerosing, although not in orthopedic surgery. We report a case of erythromycin seromadesis in orthopedic surgery.

CASE PRESENTATION: We present a case of a 63-year-old woman having undergone femoral prosthesis surgery and total hip replacement with a subfacial seroma without findings of infection, refractory to standard treatment of compression bandages, massage and cleaning surgery in two oportunities. A literature review was undertaken to obtain the therapeutic alternatives where erythromycin seromadesis is chosen with excellent response.

CONCLUSION: Erythromycin sclerotherapy should be considered as an effective and safe option in the treatment of seroma in general surgery and traumatology. More studies are necessary to get a better evidence. We believe that this is the first study of use of erythromycin as sclerotherapy in a traumatology case.

Keywords: Arthroplasty; Erythromycin; Seromadesis

Conflict of interest statement

Conflict of Interest: Nil

References

  1. Am J Surg. 2008 Oct;196(4):541-4 - PubMed
  2. J Surg Educ. 2007 Jan-Feb;64(1):41-5 - PubMed
  3. Phlebology. 2013 Oct;28(7):341-6 - PubMed
  4. Eur Surg Res. 2001 May-Jun;33(3):245-8 - PubMed
  5. J Breast Cancer. 2012 Dec;15(4):373-80 - PubMed
  6. Breast J. 2006 Sep-Oct;12(5):502-4 - PubMed
  7. Plast Reconstr Surg. 2003 Sep;112(3):934 - PubMed
  8. Int J Gynaecol Obstet. 2003 Apr;81(1):41-5 - PubMed
  9. J Plast Reconstr Aesthet Surg. 2009 Mar;62(3):e55-8 - PubMed

Publication Types